HIV Associated Polyneuropathy

Neurology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

WinSanTor
WinSanTorCA - San Diego
1 program
1
WST-057Phase 21 trial
Active Trials
NCT05005078CompletedEst. Jan 2023

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
WinSanTorWST-057

Clinical Trials (1)

NCT05005078WinSanTorWST-057

A 16-Week Study of Pirenzepine or Placebo to Treat HIV-Associated Distal Sensory Polyneuropathy in Patients With HIV

Start: Feb 2022Est. completion: Jan 2023
Phase 2Completed

Related Jobs in Neurology

Director, Distribution & Services

Xenon Pharmaceuticals
Remote
11h ago

Senior Medical Science Liaison (NYC Tri-State)

Xenon Pharmaceuticals
Remote
11h ago
$208K - $234K/yr

Director of Medical Affairs

CoMind
Miami, FL
11h ago

Director of Finance

CoMind
London, UK
11h ago

Electronics Engineering Manager

CoMind
London, UK
11h ago

Director of Information Technology

Zavation Medical Products
11h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Multiple Sclerosis(274)Schizophrenia(255)Epilepsy(242)Parkinson Disease(171)Alzheimer's Disease(165)Parkinson's Disease(160)Alzheimer Disease(117)Stroke(102)Relapsing-Remitting Multiple Sclerosis(83)Depression(82)